Bioorganic & Medicinal Chemistry Letters · 2007 · 33 citations · 6 references
MedicineMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryMolecular OncologyCell Cycle PharmacologyCell-cycle CheckpointsEnzyme InhibitionHit DiscoveryMolecular Targets Of DrugsTyrosine Kinase InhibitorsBenzimidazole ChemistryCheckpoint Kinase 2 SignalingCheckpoint Kinase InhibitionCheckpoint Kinase SignalingKinase InhibitorsProtein Kinase InhibitorsTargeted Kinase Inhibition
6
The ATM–Chk2–Cdc25A checkpoint pathway guards against radioresistant DNA synthesis
Jacob Falck, Niels Mailand, Randi G. Syljuåsen et al. · Nature · 2001 · 1.1K citations
Chk2‐deficient mice exhibit radioresistance and defective p53‐mediated transcription
Hiroyuki Takai, Kazuhito Naka, Yuki Okada et al. · The EMBO Journal · 2002 · 435 citations · Full text
Medicine, Cancer Biology, Genetics +14
Identification of novel, selective and potent Chk2 inhibitors
Gary Larson, Shunqi Yan, Huanming Chen et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 40 citations · Full text